{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T12:19:09Z","timestamp":1794917949518,"version":"4.9.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,5,2]],"date-time":"2017-05-02T00:00:00Z","timestamp":1493683200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"IMI-COMBACTE","award":["115523"],"award-info":[{"award-number":["115523"]}]},{"name":"IMI-COMBACTE","award":["115523"],"award-info":[{"award-number":["115523"]}]},{"name":"IMI-COMBACTE","award":["115523"],"award-info":[{"award-number":["115523"]}]},{"name":"IMI-COMBACTE","award":["115523"],"award-info":[{"award-number":["115523"]}]},{"name":"IMI-COMBACTE","award":["115523"],"award-info":[{"award-number":["115523"]}]},{"name":"IMI-COMBACTE","award":["115523"],"award-info":[{"award-number":["115523"]}]},{"name":"IMI-COMBACTE","award":["115523"],"award-info":[{"award-number":["115523"]}]},{"name":"IMI-COMBACTE","award":["115523"],"award-info":[{"award-number":["115523"]}]},{"name":"IMI-COMBACTE","award":["115523"],"award-info":[{"award-number":["115523"]}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["WO 1746\/1-2"],"award-info":[{"award-number":["WO 1746\/1-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s00134-017-4802-4","type":"journal-article","created":{"date-parts":[[2017,5,2]],"date-time":"2017-05-02T07:45:41Z","timestamp":1493711141000},"page":"1002-1012","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Appropriate endpoints for evaluation of new antibiotic therapies for severe infections: a perspective from COMBACTE\u2019s STAT-Net"],"prefix":"10.1007","volume":"43","author":[{"name":"on behalf of the COMBACTE-NET consortium","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0903-8614","authenticated-orcid":false,"given":"Jean-Fran\u00e7ois","family":"Timsit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlieke E. A.","family":"de Kraker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harriet","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Bettiol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Wolkewitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros","family":"Nikolakopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Harbarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,2]]},"reference":[{"issue":"Suppl 1","key":"4802_CR1","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1086\/653060","volume":"51","author":"JG Muscedere","year":"2010","unstructured":"Muscedere JG, Day A, Heyland DK (2010) Mortality, attributable mortality, and clinical events as end points for clinical trials of ventilator-associated pneumonia and hospital-acquired pneumonia. Clin Infect Dis 51(Suppl 1):S120\u2013S125","journal-title":"Clin Infect Dis"},{"key":"4802_CR2","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/cid\/cis566","volume":"55","author":"GH Talbot","year":"2012","unstructured":"Talbot GH, Powers JH, Fleming TR, Siuciak JA, Bradley J, Boucher H (2012) Progress on developing endpoints for registrational clinical trials of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections: update from the Biomarkers Consortium of the Foundation for the National Institutes of Health. Clin Infect Dis 55:1114\u20131121","journal-title":"Clin Infect Dis"},{"key":"4802_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2016.10.023","author":"PN Harris","year":"2016","unstructured":"Harris PN, McNamara JF, Lye DC, Davis JS, Bernard L, Cheng AC, Doi Y, Fowler VG, Jr., Kaye KS, Leibovici L, Lipman J, Llewelyn MJ, Munoz-Price S, Paul M, Peleg AY, Rodriguez-Bano J, Rogers BA, Seifert H, Thamlikitkul V, Thwaites G, Tong SY, Turnidge J, Utili R, Webb SA, Paterson DL (2016) Proposed primary endpoints for use in clinical trials that compare treatment options for bloodstream infection in adults: a consensus definition. Clin Microbiol Infect. doi:\n                        10.1016\/j.cmi.2016.10.023","journal-title":"Clin Microbiol Infect"},{"key":"4802_CR4","volume-title":"Guidance for industry hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia: developing drugs for treatment","author":"U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research","year":"2014","unstructured":"U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (2014) Guidance for industry hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia: developing drugs for treatment. Center for Drug Evaluation and Research, Silver Spring"},{"key":"4802_CR5","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1097\/CCM.0b013e31817b879c","volume":"36","author":"M Garrouste Orgeas","year":"2008","unstructured":"Garrouste Orgeas M, Timsit JF, Soufir L, Tafflet M, Adrie C, Philippart F, Zahar JR, Clec\u2019h C, Goldran-Toledano D, Jamali S, Dumenil AS, Azoulay E, Carlet J (2008) Impact of adverse events on outcomes in intensive care unit patients. Crit Care Med 36:2041\u20132047","journal-title":"Crit Care Med"},{"key":"4802_CR6","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1164\/rccm.201105-0867OC","volume":"184","author":"M Bekaert","year":"2011","unstructured":"Bekaert M, Timsit JF, Vansteelandt S, Depuydt P, Vesin A, Garrouste-Orgeas M, Decruyenaere J, Clec\u2019h C, Azoulay E, Benoit D (2011) Attributable mortality of ventilator-associated pneumonia: a reappraisal using causal analysis. Am J Respir Crit Care Med 184:1133\u20131139","journal-title":"Am J Respir Crit Care Med"},{"key":"4802_CR7","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1007\/s00134-016-4444-y","volume":"42","author":"V Pettila","year":"2016","unstructured":"Pettila V, Hjortrup PB, Jakob SM, Wilkman E, Perner A, Takala J (2016) Control groups in recent septic shock trials: a systematic review. Intensive Care Med 42:1912\u20131921","journal-title":"Intensive Care Med"},{"key":"4802_CR8","doi-asserted-by":"crossref","first-page":"h2147","DOI":"10.1136\/bmj.h2147","volume":"350","author":"K Loudon","year":"2015","unstructured":"Loudon K, Treweek S, Sullivan F, Donnan P, Thorpe KE, Zwarenstein M (2015) The PRECIS-2 tool: designing trials that are fit for purpose. BMJ 350:h2147","journal-title":"BMJ"},{"key":"4802_CR9","volume-title":"Severe hospital-acquired and ventilatory-acquired pneumonia treatment: a systematic review of inclusion and judgement criteria used in RCTs","author":"E Weiss","year":"2015","unstructured":"Weiss E, Zahar JR, Adrie C, Wolkewitz M, Essaied W, Timsit JF (2015) Severe hospital-acquired and ventilatory-acquired pneumonia treatment: a systematic review of inclusion and judgement criteria used in RCTs. ECCMID, Copenhagen"},{"key":"4802_CR10","doi-asserted-by":"crossref","unstructured":"Sommer H, Wolkewitz M, Schumacher M (2017) The time-dependent \u2018cure-death\u2019 model investigating two equally important endpoints simultaneously in trials treating high-risk patients with resistant pathogens. Pharm Stat (in press)","DOI":"10.1002\/pst.1809"},{"issue":"Suppl 1","key":"4802_CR11","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1086\/653035","volume":"51","author":"MS Niederman","year":"2010","unstructured":"Niederman MS (2010) Hospital-acquired pneumonia, health care-associated pneumonia, ventilator-associated pneumonia, and ventilator-associated tracheobronchitis: definitions and challenges in trial design. Clin Infect Dis 51(Suppl 1):S12\u2013S17","journal-title":"Clin Infect Dis"},{"key":"4802_CR12","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.amjmed.2003.07.005","volume":"115","author":"S Harbarth","year":"2003","unstructured":"Harbarth S, Garbino J, Pugin J, Romand JA, Lew D, Pittet D (2003) Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 115:529\u2013535","journal-title":"Am J Med"},{"key":"4802_CR13","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S1473-3099(13)70081-1","volume":"13","author":"WG Melsen","year":"2013","unstructured":"Melsen WG, Rovers MM, Groenwold RH, Bergmans DC, Camus C, Bauer TT, Hanisch EW, Klarin B, Koeman M, Krueger WA, Lacherade JC, Lorente L, Memish ZA, Morrow LE, Nardi G, van Nieuwenhoven CA, O\u2019Keefe GE, Nakos G, Scannapieco FA, Seguin P, Staudinger T, Topeli A, Ferrer M, Bonten MJ (2013) Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies. Lancet Infect Dis 13:665\u2013671","journal-title":"Lancet Infect Dis"},{"key":"4802_CR14","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/MCC.0b013e32834a5ae9","volume":"17","author":"JF Timsit","year":"2011","unstructured":"Timsit JF, Zahar JR, Chevret S (2011) Attributable mortality of ventilator-associated pneumonia. Curr Opin Crit Care 17:464\u2013471","journal-title":"Curr Opin Crit Care"},{"key":"4802_CR15","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1164\/ajrccm.153.1.8542110","volume":"153","author":"KM Cunnion","year":"1996","unstructured":"Cunnion KM, Weber DJ, Broadhead WE, Hanson LC, Pieper CF, Rutala WA (1996) Risk factors for nosocomial pneumonia: comparing adult critical-care populations. Am J Respir Crit Care Med 153:158\u2013162","journal-title":"Am J Respir Crit Care Med"},{"key":"4802_CR16","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1086\/523279","volume":"28","author":"C Clec\u2019h","year":"2007","unstructured":"Clec\u2019h C, Schwebel C, Francais A, Toledano D, Fosse JP, Garrouste-Orgeas M, Azoulay E, Adrie C, Jamali S, Descorps-Declere A, Nakache D, Timsit JF, Cohen Y (2007) Does catheter-associated urinary tract infection increase mortality in critically ill patients? Infect Control Hosp Epidemiol 28:1367\u20131373","journal-title":"Infect Control Hosp Epidemiol"},{"key":"4802_CR17","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1086\/500318","volume":"42","author":"M Garrouste-Orgeas","year":"2006","unstructured":"Garrouste-Orgeas M, Timsit JF, Tafflet M, Misset B, Zahar JR, Soufir L, Lazard T, Jamali S, Mourvillier B, Cohen Y, De Lassence A, Azoulay E, Cheval C, Descorps-Declere A, Adrie C, Costa de Beauregard MA, Carlet J (2006) Excess risk of death from intensive care unit-acquired nosocomial bloodstream infections: a reappraisal. Clin Infect Dis 42:1118\u20131126","journal-title":"Clin Infect Dis"},{"key":"4802_CR18","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1086\/650754","volume":"31","author":"JM Januel","year":"2010","unstructured":"Januel JM, Harbarth S, Allard R, Voirin N, Lepape A, Allaouchiche B, Guerin C, Lehot JJ, Robert MO, Fournier G, Jacques D, Chassard D, Gueugniaud PY, Artru F, Petit P, Robert D, Mohammedi I, Girard R, Cetre JC, Nicolle MC, Grando J, Fabry J, Vanhems P (2010) Estimating attributable mortality due to nosocomial infections acquired in intensive care units. Infect Control Hosp Epidemiol 31:388\u2013394","journal-title":"Infect Control Hosp Epidemiol"},{"key":"4802_CR19","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1086\/656737","volume":"51","author":"L Bouadma","year":"2010","unstructured":"Bouadma L, Deslandes E, Lolom I, Le Corre B, Mourvillier B, Regnier B, Porcher R, Wolff M, Lucet JC (2010) Long-term impact of a multifaceted prevention program on ventilator-associated pneumonia in a medical intensive care unit. Clin Infect Dis 51:1115\u20131122","journal-title":"Clin Infect Dis"},{"key":"4802_CR20","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/CCM.0b013e31827c09f8","volume":"41","author":"DF Gaieski","year":"2013","unstructured":"Gaieski DF, Edwards JM, Kallan MJ, Carr BG (2013) Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med 41:1167\u20131174","journal-title":"Crit Care Med"},{"key":"4802_CR21","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1001\/jama.2014.2637","volume":"311","author":"KM Kaukonen","year":"2014","unstructured":"Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R (2014) Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000\u20132012. JAMA 311:1308\u20131316","journal-title":"JAMA"},{"key":"4802_CR22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40560-016-0151-6","volume":"4","author":"A Mebazaa","year":"2016","unstructured":"Mebazaa A, Laterre PF, Russell JA, Bergmann A, Gattinoni L, Gayat E, Harhay MO, Hartmann O, Hein F, Kjolbye AL, Legrand M, Lewis RJ, Marshall JC, Marx G, Radermacher P, Schroedter M, Scigalla P, Stough WG, Struck J, Van den Berghe G, Yilmaz MB, Angus DC (2016) Designing phase 3 sepsis trials: application of learned experiences from critical care trials in acute heart failure. J Intensive Care 4:24","journal-title":"J Intensive Care"},{"issue":"Suppl 1","key":"4802_CR23","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1086\/653038","volume":"51","author":"A Sorbello","year":"2010","unstructured":"Sorbello A, Komo S, Valappil T, Nambiar S (2010) Registration trials of antibacterial drugs for the treatment of nosocomial pneumonia. Clin Infect Dis 51(Suppl 1):S36\u2013S41","journal-title":"Clin Infect Dis"},{"key":"4802_CR24","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1097\/CCM.0000000000001091","volume":"43","author":"L Bouadma","year":"2015","unstructured":"Bouadma L, Sonneville R, Garrouste-Orgeas M, Darmon M, Souweine B, Voiriot G, Kallel H, Schwebel C, Goldgran-Toledano D, Dumenil AS, Argaud L, Ruckly S, Jamali S, Planquette B, Adrie C, Lucet JC, Azoulay E, Timsit JF (2015) Ventilator-associated events: prevalence, outcome, and relationship with ventilator-associated pneumonia. Crit Care Med 43:1798\u20131806","journal-title":"Crit Care Med"},{"key":"4802_CR25","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1164\/ajrccm.163.6.2007020","volume":"163","author":"PJ Dennesen","year":"2001","unstructured":"Dennesen PJ, van der Ven AJ, Kessels AG, Ramsay G, Bonten MJ (2001) Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia. Am J Respir Crit Care Med 163:1371\u20131375","journal-title":"Am J Respir Crit Care Med"},{"key":"4802_CR26","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jcrc.2007.11.010","volume":"23","author":"AF Shorr","year":"2008","unstructured":"Shorr AF, Cook D, Jiang X, Muscedere J, Heyland D (2008) Correlates of clinical failure in ventilator-associated pneumonia: insights from a large, randomized trial. J Crit Care 23:64\u201373","journal-title":"J Crit Care"},{"key":"4802_CR27","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0140-6736(09)61879-1","volume":"375","author":"L Bouadma","year":"2010","unstructured":"Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C, Schortgen F, Lasocki S, Veber B, Dehoux M, Bernard M, Pasquet B, Regnier B, Brun-Buisson C, Chastre J, Wolff M (2010) Use of procalcitonin to reduce patients\u2019 exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 375:463\u2013474","journal-title":"Lancet"},{"key":"4802_CR28","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1001\/jama.2012.5833","volume":"307","author":"FM Brunkhorst","year":"2012","unstructured":"Brunkhorst FM, Oppert M, Marx G, Bloos F, Ludewig K, Putensen C, Nierhaus A, Jaschinski U, Meier-Hellmann A, Weyland A, Grundling M, Moerer O, Riessen R, Seibel A, Ragaller M, Buchler MW, John S, Bach F, Spies C, Reill L, Fritz H, Kiehntopf M, Kuhnt E, Bogatsch H, Engel C, Loeffler M, Kollef MH, Reinhart K, Welte T, German Study Group Competence Network S (2012) Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial. JAMA 307:2390\u20132399","journal-title":"JAMA"},{"key":"4802_CR29","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.coph.2015.07.001","volume":"24","author":"P Viale","year":"2015","unstructured":"Viale P, Giannella M, Tedeschi S, Lewis R (2015) Treatment of MDR-Gram negative infections in the 21st century: a never ending threat for clinicians. Curr Opin Pharmacol 24:30\u201337","journal-title":"Curr Opin Pharmacol"},{"key":"4802_CR30","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Expert Working Group (1998) Guideline E9: \u201cStatistical Principles for Clinical Trials\u201d. Available at: \n                        http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Efficacy\/E9\/Step4\/E9_Guideline.pdf\n                        \n                    . Accessed Sept 2016"},{"key":"4802_CR31","doi-asserted-by":"crossref","first-page":"e34785","DOI":"10.1371\/journal.pone.0034785","volume":"7","author":"J Pogue","year":"2012","unstructured":"Pogue J, Devereaux PJ, Thabane L, Yusuf S (2012) Designing and analyzing clinical trials with composite outcomes: consideration of possible treatment differences between the individual outcomes. PLoS ONE 7:e34785","journal-title":"PLoS ONE"},{"key":"4802_CR32","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/eurheartj\/ehr352","volume":"33","author":"SJ Pocock","year":"2012","unstructured":"Pocock SJ, Ariti CA, Collier TJ, Wang D (2012) The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities. Eur Heart J 33:176\u2013182","journal-title":"Eur Heart J"},{"key":"4802_CR33","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/cid\/civ495","volume":"61","author":"SR Evans","year":"2015","unstructured":"Evans SR, Rubin D, Follmann D, Pennello G, Huskins WC, Powers JH, Schoenfeld D, Chuang-Stein C, Cosgrove SE, Fowler VG Jr, Lautenbach E, Chambers HF (2015) Desirability of outcome ranking (DOOR) and response adjusted for duration of antibiotic risk (RADAR). Clin Infect Dis 61:800\u2013806","journal-title":"Clin Infect Dis"},{"key":"4802_CR34","unstructured":"Celestin A, Odom S, Sawyer R, Cook C (2016) Novel method allows proof of superiority in antibiotic trials using smaller cohorts. 36th annual SIS Meeting. Surgical infections, 17, S21"},{"key":"4802_CR35","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/cid\/civ496","volume":"61","author":"J Molina","year":"2015","unstructured":"Molina J, Cisneros JM (2015) Editorial commentary: a chance to change the paradigm of outcome assessment of antimicrobial stewardship programs. Clin Infect Dis 61:807\u2013808","journal-title":"Clin Infect Dis"},{"key":"4802_CR36","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/cid\/civ1002","volume":"62","author":"PP Phillips","year":"2016","unstructured":"Phillips PP, Morris TP, Walker AS (2016) DOOR\/RADAR: a gateway into the unknown? Clin Infect Dis 62:814\u2013815","journal-title":"Clin Infect Dis"},{"key":"4802_CR37","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1002\/sim.6233","volume":"33","author":"MF Huque","year":"2014","unstructured":"Huque MF, Valappil T, Soon GG (2014) Hierarchical nested trial design (HNTD) for demonstrating treatment efficacy of new antibacterial drugs in patient populations with emerging bacterial resistance. Stat Med 33:4321\u20134336","journal-title":"Stat Med"},{"key":"4802_CR38","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1164\/rccm.201401-0056CP","volume":"189","author":"MO Harhay","year":"2014","unstructured":"Harhay MO, Wagner J, Ratcliffe SJ, Bronheim RS, Gopal A, Green S, Cooney E, Mikkelsen ME, Kerlin MP, Small DS, Halpern SD (2014) Outcomes and statistical power in adult critical care randomized trials. Am J Respir Crit Care Med 189:1469\u20131478","journal-title":"Am J Respir Crit Care Med"},{"key":"4802_CR39","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/19466315.2015.1096824","volume":"7","author":"DL Price","year":"2015","unstructured":"Price DL, Rubin DB, Valappil T (2015) Antimicrobial products: statistical challenges and opportunities. Stat Biopharm Res 7:325\u2013330","journal-title":"Stat Biopharm Res"},{"key":"4802_CR40","volume-title":"Competing risks and multistate models with R","author":"J Beyersmann","year":"2011","unstructured":"Beyersmann J, Allignol A, Schumacher M (2011) Competing risks and multistate models with R. Springer, New York"},{"key":"4802_CR41","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1093\/ije\/dyt111","volume":"42","author":"M Schumacher","year":"2013","unstructured":"Schumacher M, Allignol A, Beyersmann J, Binder N, Wolkewitz M (2013) Hospital-acquired infections\u2014appropriate statistical treatment is urgently needed! Int J Epidemiol 42:1502\u20131508","journal-title":"Int J Epidemiol"},{"key":"4802_CR42","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s00134-015-4167-5","volume":"42","author":"L Ayzac","year":"2016","unstructured":"Ayzac L, Girard R, Baboi L, Beuret P, Rabilloud M, Richard JC, Guerin C (2016) Ventilator-associated pneumonia in ARDS patients: the impact of prone positioning. A secondary analysis of the PROSEVA trial. Intensive Care Med 42:871\u2013878","journal-title":"Intensive Care Med"},{"key":"4802_CR43","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1586\/14737140.2015.1047768","volume":"15","author":"F Fiteni","year":"2015","unstructured":"Fiteni F, Pam A, Anota A, Vernerey D, Paget-Bailly S, Westeel V, Bonnetain F (2015) Health-related quality-of-life as co-primary endpoint in randomized clinical trials in oncology. Expert Rev Anticancer Ther 15:885\u2013891","journal-title":"Expert Rev Anticancer Ther"},{"key":"4802_CR44","doi-asserted-by":"publisher","unstructured":"Pugh R, Grant C, Cooke RP, Dempsey G (2015) Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults. Cochrane Database Syst Rev: CD007577. doi:\n                        10.1002\/14651858.CD007577","DOI":"10.1002\/14651858.CD007577"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00134-017-4802-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-017-4802-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-017-4802-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T09:59:10Z","timestamp":1498211950000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00134-017-4802-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,2]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["4802"],"URL":"https:\/\/doi.org\/10.1007\/s00134-017-4802-4","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,2]]}}}